Interventional Therapy of Tracheal Stenosis
1 other identifier
observational
250
1 country
1
Brief Summary
After respiratory weaning, decannulation is sought. To do this, the tracheal cannula is first unblocked, so that patients no longer breathe in and out through the cannula, but (at least partially) "passing" the cannula by the natural route. In the presence of tracheal stenosis there is increased breathing effort, possibly restlessness and stridor. This constellation of symptoms suggests the suspicion of tracheal stenosis, so in the next step a tracheoscopy is performed to confirm or exclude tracheal stenosis. In case of symptomatic tracheal stenosis and at least 30-50% stenosis of the trachea (clinical symptoms can be expected from a 30-50% stenosis) then appropriate therapy (here: cryotherapy, other techniques only in exceptional cases) is planned. The goal is to be able to remove the tracheal cannula (long term) after successful therapy, so that patients do not have to be permanently provided with a tracheal cannula. There is no definitive/evidence-based standard therapy for the treatment of tracheal stenosis. Cryotherapy is a gentle therapy that has already been applied and described for the treatment of tracheal stenosis (see above). The examination is performed as part of an analgesic dose, as is routine for a bronchoscopy (in-house SOP). After treatment, a follow-up is planned for about 10 days later.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2023
CompletedFirst Submitted
Initial submission to the registry
June 10, 2023
CompletedFirst Posted
Study publicly available on registry
June 29, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2026
ExpectedJuly 31, 2024
July 1, 2024
2.6 years
June 10, 2023
July 30, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Decannulation
Rate of successful decannulations after intervention up to discharge from inpatient treatment.
12 months
Secondary Outcomes (5)
Technical success
12 months
Reintervention(s)
12 months
Type of intervention
12 months
Clinical success
12 months
Additional treatment
12 months
Eligibility Criteria
Patients after successfull respiratory weaning with symptomatic trachealstenosis
You may qualify if:
- Tracheal stenosis after percutaneous tracheotomy.
You may not qualify if:
- Pregnant or breast-feeding women of childbearing potential who refuse pregnancy test.
- lack of consent to participate in the study.
- surgical tracheotomy.
- Involvement of the larynx (above the first tracheal brace).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Neurologische Klinik Bad Salzhausen
Nidda, 63667, Germany
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Target Duration
- 10 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 10, 2023
First Posted
June 29, 2023
Study Start
June 1, 2023
Primary Completion
December 31, 2025
Study Completion (Estimated)
July 31, 2026
Last Updated
July 31, 2024
Record last verified: 2024-07